Affordable Access

deepdyve-link
Publisher Website

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis.

Authors
  • Cohen, Bruce A
  • Rivera, Victor M
Type
Published Article
Journal
Current Medical Research and Opinion
Publisher
Informa UK (Librapharm)
Publication Date
Apr 01, 2010
Volume
26
Issue
4
Pages
827–838
Identifiers
DOI: 10.1185/03007991003604018
PMID: 20121658
Source
Medline
License
Unknown

Abstract

Class I and long-term data from PRISMS support the use of sc IFN beta-1a tiw as a first-line treatment for MS, as evidenced by sustained efficacy rates, acceptable safety profiles, and high patient retention rates.

Report this publication

Statistics

Seen <100 times